Failure of Quality Control Measures To Prevent Reporting of False Resistance to Imipenem, Resulting in a Pseudo-Outbreak of Imipenem-Resistant Pseudomonas aeruginosa-Reference-Cited by-同舟云学术

Failure of Quality Control Measures To Prevent Reporting of False Resistance to Imipenem, Resulting in a Pseudo-Outbreak of Imipenem-Resistant Pseudomonas aeruginosa

Published:1998-02 Issue:2 Volume:36 Page:595-597
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Carmeli Yehuda¹,Eichelberger Karen²,Soja Don³,Dakos Joanna²,Venkataraman Lata²,DeGirolami Paola²,Samore Matthew¹

Affiliation:

1. Division of Infectious Diseases1 and

2. Department of Pathology,2 Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, and

3. Health Sciences Services, Merck & Co. Inc., West Point, Pennsylvania3

Abstract

ABSTRACT False results showing an outbreak of Pseudomonas aeruginosa with resistance to imipenem were traced to a defective lot of microdilution MIC testing panels. These panels contained two- to threefold lower concentrations of imipenem than expected and resulted in artifactual two- to fourfold increases in MICs of imipenem. The quality-control MIC results for Pseudomonas aeruginosa ATCC 27853 were 4 μg/ml, the highest value within the range recommended by the National Committee for Clinical Laboratory Standards. We recommend that this value be considered out of the quality-control range.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.36.2.595-597.1998

Reference9 articles.

1. Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting

2. Imipenem stability in a predried susceptibility panel

3. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests 6th ed. Approved standard M2-A6. 1997 National Committee for Clinical Laboratory Standards Wayne Pa

4. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 6th ed. Approved standard M7-A4. 1997 National Committee for Clinical Laboratory Standards Wayne Pa

5. False resistance to imipenem with a microdilution susceptibility testing system;O’Rouke E. J.;J. Clin. Microbiol.,1991

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales from patients with intra-abdominal infections: Results of the study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2020;Journal of Microbiology, Immunology and Infection;2023-02

2. The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study;Diagnostic Microbiology and Infectious Disease;2011-07

3. Expert Systems in Clinical Microbiology;Clinical Microbiology Reviews;2011-07

4. Contribución del laboratorio de microbiología en la vigilancia y el control de brotes nosocomiales producidos por bacilos gramnegativos no fermentadores;Enfermedades Infecciosas y Microbiología Clínica;2011-03

5. Accuracy of Detecting Resistance to Carbapenems among Gram Negative Rods: Comparison of Three Methods;Journal of Taibah University Medical Sciences;2009